KALA Kala Pharmaceuticals Inc.

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

$0.30  -0.02 (-6.25%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/20/2017
Outstanding shares:  72,594,005
Average volume:  2,185,350
Market cap:   $23,230,082
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF2F1K4
Valuation   (See tab for details)
PE ratio:   -0.15
PB ratio:   1.17
PS ratio:   2.49
Return on equity:   2,746.67%
Net income %:   -1,552.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy